Meningococcal group C and W135 immunological hyporesponsiveness in African toddlers

Clinical and Vaccine Immunology

Volumn 18, Issue 9, 2011, Pages 1492-1496

  Findlow, Helen ^a   Sow, Samba ^b   Borrow, Ray ^a,c   Tapia, Milagritos ^b   Haidara, Fadima Cheick ^b   Akinsola, Adebayo K ^d   Idoko, Olubukola T ^d   Diallo, Fatoumata ^b   Adegbola, Richard ^d   Tang, Yuxiao ^e   Parulekar, Varsha ^f   Chadha, Helen ^a   Mabey, Lesley ^a   Holme, Daniel ^a   Townsend, Kelly ^a   Chaumont, Julie ^e   LaForce, F Marc ^e   Kulkarni, Prasad S ^g   Marchetti, Elisa ^e   Viviani, Simonetta ^e   Hassan King, Musa ^e   Preziosi, Marie Pierre ^h   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Centre pour le Developpment des Vaccins (CVD Mali)   (Mali)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e PATH   (France)

^f DiagnoSearch Life Sciences   (India)

^g Serum Institute of India Ltd   (India)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AFRICA; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD GROUP TYPING; BLOOD SAMPLING; CHILD; CHILD HEALTH; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ETHNIC GROUP; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; INFANT; MASS IMMUNIZATION; MENINGOCOCCOSIS; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TODDLER;

ANIMALS; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; GAMBIA; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INFANT; MALI; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP C; NEISSERIA MENINGITIDIS, SEROGROUP W-135; RABBITS; SEROTYPING; TREATMENT OUTCOME; VACCINES, CONJUGATE;

EID: 80052482936     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05020-11     Document Type: Article

References (16)

1. Al-Mazrou, Y. Y., et al. 2005. Immunogenicity of a meningococcal ACYW135 polysaccharide vaccine in Saudi children aged under 5 years. Infect. Immun. 73:2932-2939.
2. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786. (Pubitemid 37129487)
3. Borrow, R. 2009. Meningococcal disease and prevention at the Hajj. Travel Med. Infect. Dis. 7:219-225.
4. Gold, R., M. L. Lepow, I. Goldschneider, T. L. Draper, and E. C. Gotschlich. 1975. Clinical evaluation of group A and group C meningococcal polysaccharide vaccine in infants. J. Clin. Invest. 56:1536-1547.
5. Jokhdar, H., et al. 2004. Immunologic hyporesponsiveness to group C but not group A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia. Clin. Diagn. Lab. Immunol. 11:83-88. (Pubitemid 38090656)
6. Keyserling, H., et al. 2005. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch. Pediatr. Adolesc. Med. 159:907-913. (Pubitemid 41423328)
7. Kshirsagar, N., et al. 2007. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults. Vaccine 25S:A101-A107. (Pubitemid 47208600)
8. Macdonald, N. E., et al. 1998. Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers. JAMA 280:1685-1689.
9. Maslanka, S. E., et al. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis group A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167. (Pubitemid 27130227)
10. Naess, L. M., P. J. Guerin, E. Rosenqvist, L. H. Kristiansen, and D. A. Caugant. 2009. Influence of prior vaccination with fractional doses of a tetravalent meningococcal polysaccharide vaccine on serum bactericidal antibody responses after revaccination, abstr. P006, p. 46. Abstr. 10th Eur. Meningococcal Dis. Soc. (EMGM) Meet., Manchester, United Kingdom.
11. Peltola, H., A. Safary, H. Käyhty, V. Karanko, and F. E. André. 1985. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: A clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics 76:91-96. (Pubitemid 15006880)
12. Pichichero, M., et al. 2006. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 25:995-1000. (Pubitemid 44657807)
13. Richmond, P., et al. 1998. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J. Infect. Dis. 178:870-874.
14. Southern, J., et al. 2004. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal group C tetanus toxoid conjugate vaccination in adults. Clin. Diagn. Lab. Immunol. 11:1100-1104. (Pubitemid 39540851)
15. Sow, S., et al. 2011. Immunogenicity and safety of a new meningococcal A conjugate vaccine in Africa. N. Engl. J. Med. 364:2293-2304.
16. Timens, W., A. Boes, T. Rozeboom-Uiterwijk, and S. Poppema. 1989. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143:3200-3206. (Pubitemid 20010145)